1.84
+0.03(+1.66%)
Currency In USD
| Previous Close | 1.81 |
| Open | 1.84 |
| Day High | 1.85 |
| Day Low | 1.72 |
| 52-Week High | 2.73 |
| 52-Week Low | 0.85 |
| Volume | 6.16M |
| Average Volume | 7.9M |
| Market Cap | 555.51M |
| PE | -0.86 |
| EPS | -2.13 |
| Moving Average 50 Days | 2.12 |
| Moving Average 200 Days | 1.6 |
| Change | 0.03 |
If you invested $1000 in Pacific Biosciences of California, Inc. (PACB) 10 years ago, it would be worth $208.85 as of February 12, 2026 at a share price of $1.84. Whereas If you bought $1000 worth of Pacific Biosciences of California, Inc. (PACB) shares 5 years ago, it would be worth $36.57 as of February 12, 2026 at a share price of $1.84.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner
GlobeNewswire Inc.
1 hours ago
Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease NetworkMENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-re
PacBio Completes Sale of Short-Read Sequencing Assets
GlobeNewswire Inc.
Feb 02, 2026 2:05 PM GMT
MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets rela
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
GlobeNewswire Inc.
Jan 27, 2026 9:05 PM GMT
MENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 p